UNSPSC 51282109: Faropenem sodium

This classification denotes a beta-lactam antibiotic with the molecular formula C12H14NO5S.NA, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7O46G914RQ. European Medicines Agency schedules faropenem sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB16432MIG. The term faropenem sodium is a U.S. FDA designation. Most nations schedule faropenem sodium under HS 29419000 and SITC 54139. As of Q4 2014, FAROPENEM SODIUM remains the US FDA Preferred Term for this commodity.

SMILES: CC(C1C2N(C1=O)C(=C(S2)C3CCCO3)C(=O)[O-])O.[NA+].

UNSPSC 51282109 Faropenem sodium is a Commodity code that nominally identifies a specific beta-lactam antibiotic, but recent state and local opportunities tagged under this code show little alignment with that narrow pharmaceutical specification. Instead, the posted solicitations under this code span a much broader range of medical and pharmaceutical products: naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, emergency medical and first aid supplies for fire rescue operations, and generic multi-source pharmaceuticals and over-the-counter products distributed through cooperative purchasing vehicles. The issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire departments (City of Tampa), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local facilities across participating jurisdictions including Oregon). The code appears to be a catch-all or miscategorization for pharmaceutical and medical supply procurements rather than a targeted code for a single active pharmaceutical ingredient.

Recent activity spans Florida, Texas, Minnesota, and Oregon. The most recent opportunity is Seminole County, Florida's IFB 60459723LAS (due Jul 26, 2023, posted Jun 30, 2026), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a two-year initial term plus one-year renewal option. The Texas Health and Human Services Commission issued RFI HHS0017013 (due Apr 3, 2026) to gather vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program. The City of Tampa released IFB 26P00145 (due Mar 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, designated as a Small Local Business Enterprise sheltered market with a $700,000 estimated contract value and a 5 percent SLBE bid discount. The Minnesota Multistate Cooperative Purchasing Alliance issued RFP S1070000015802 (due Mar 26, 2026) for generic multi-source pharmaceuticals and OTC products, requiring products through three authorized wholesalers with a July 1, 2026 effective date for awarded vendors and a two-year contract term. The code shows no substantial market concentration and little coherence with its nominal scope.